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Mechanistic Understanding of the 
interactions of cationic conjugated 
oligo- and polyelectrolytes with 
Wild-type and Ampicillin-resistant 
Escherichia coli
ehsan Zamani1, Shyambo chatterjee1, taity changa1, cheryl immethun1, 
Anandakumar Sarella2, Rajib Saha1 & Shudipto Konika Dishari1*
An in-depth understanding of cell-drug binding modes and action mechanisms can potentially guide 
the future design of novel drugs and antimicrobial materials and help to combat antibiotic resistance. 
Light-harvesting π-conjugated molecules have been demonstrated for their antimicrobial effects, 
but their impact on bacterial outer cell envelope needs to be studied in detail. Here, we synthesized 
poly(phenylene) based model cationic conjugated oligo- (2QA-CCOE, 4QA-CCOE) and polyelectrolytes 
(ccpe), and systematically explored their interactions with the outer cell membrane of wild-type and 
ampicillin (amp)-resistant Gram-negative bacteria, Escherichia coli (E. coli). incubation of the E. coli 
cells in CCOE/CCPE solution inhibited the subsequent bacterial growth in LB media. About 99% growth 
inhibition was achieved if amp-resistant E. coli was treated for ~3–5 min, 1 h and 6 h with 100 μM 
of CCPE, 4QA-CCOE, and 2QA-CCOE solutions, respectively. Interestingly, these CCPE and CCOEs 
inhibited the growth of both wild-type and amp-resistant E. coli to a similar extent. A large surface 
charge reversal of bacteria upon treatment with ccpe suggested the formation of a coating of ccpe on 
the outer surface of bacteria; while a low reversal of bacterial surface charge suggested intercalation of 
ccoes within the lipid bilayer of bacteria.
Antibiotic resistance is an emerging global concern that requires immediate attention. In addition to regulating 
the use of the antibiotics, we need to focus on the development of alternate antibiotics based on a solid under-
standing of the drug-cell interactions. The cell walls of many Gram-negative bacteria play a critical role in mod-
ulating antibiotic resistance. The cell wall of E. coli, a Gram-negative bacterium, consists of an outer1 and inner 
membrane separated by a periplasmic space. The major constituents of the lipid bilayer2 on the outer membrane 
of Gram-negative bacteria are lipopolysaccharides (LPSs) having zwitterionic core oligosaccharides3,4; saturated 
fatty acid chains with zwitterionic phospholipid head groups5, and, lipid A functionalized with anionic phosphate 
groups6–8. The outer membrane also consists of porins9 which are proteins (charged) that allow the penetration of 
drugs, nutrients and small molecules inside bacterial cells. The periplasmic space under the lipid bilayer of outer 
membrane contains cross-linked peptidoglycans5. β-lactam antibiotics (such as ampicillin), when in action on 
wild-type E. coli, are able to penetrate through porins present on the outer cell envelope and reach to periplas-
mic space where the drugs inhibit the formation of peptidoglycan cross-linkages and block the cell division10,11. 
The most common ways Gram-negative bacteria show antibiotic resistance are: (i) by cleaving the antibiotic 
drugs (such as β-lactam) in the periplasmic space through secretion of enzymes (such as β-lactamase)12; (ii) by 
decreasing the number and size of the porins facilitating drug transport13,14; and, (iii) by altering the preferential 
permeation of certain species and transverse electrostatic field15 within the constriction zones of porins where 
the antibiotic docks before translocation inside the cells. These facts suggest that the charged nature of the outer 
1Department of Chemical and Biomolecular Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, 68588, 
United States. 2Nebraska Center for Materials and Nanoscience, Voelte-Keegan Nanoscience Research Center, 
University of Nebraska-Lincoln, Lincoln, NE, 68588-0298, United States. *email: sdishari2@unl.edu
open
2Scientific RepoRtS |         (2019) 9:20411  | https://doi.org/10.1038/s41598-019-56946-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
cell envelope can play critical roles in the electrostatic binding interactions, transport of charged molecules, and 
ultimate killing/inhibitory actions of the drugs on both wild-type and antibiotic-resistant bacteria.
While β-lactams are widely used to treat infections associated with Gram-negative bacteria, the emergence of 
resistance to this class of antibiotics has led researchers to find alternative drugs. The two major classes of alter-
nate candidates are cationic, gene-encoded antimicrobial peptides (AMPs)16–20, and, π-conjugated oligo/polyelec-
trolytes18,21–27. Initial studies suggested that bacteria still find it difficult to show resistance against the second class 
of antimicrobial molecules24. Conjugated molecules have unique light-harvesting, π-conjugated and hydrophobic 
backbones with charged functional groups as pendants. Cationic, water-soluble oligo- (CCOEs) and polyelectro-
lytes (CCPEs) can thus bind to the bacterial cell wall through electrostatic and hydrophobic interactions. In the 
efforts of designing small (CCOEs) and large (CCPEs)conjugated molecules, phenylene vinylene26,28, phenylene 
ethynylene 18,29, fluorene22,30, or thiophene22,31 are commonly used as backbone repeat units (RUs), while quater-
nary amine groups are used to impart positively charged functionalities to the conjugated molecules. The antimi-
crobial efficiency was influenced by the location and density of charged groups, backbone structure, chain length, 
and, the water solubility of CCOEs and CCPEs 6,18,21,23,28,29. Shorter side-chain CCOEs often appeared to be more 
toxic (lower minimum inhibitory concentration) to bacteria due to their intercalation within the lipid bilayer of 
the bacterial cell wall6,21,28,29,32,33. On the other hand, some other dominant antimicrobial actions (by CCOEs/
CCPEs) took place via coating18,23,30, disruption of the lipid bilayer18,32, disintegration of the bacterial cytoplasmic 
membrane (bacteriolysis)23, and/or formation of reactive oxygen species (light-assisted)27,34,35. Combination ther-
apies were also proposed where AMPs and CCPEs acted synergistically22,30.
While phenylene vinylene26,28, and phenylene ethynylene18,29 based conjugated molecules have been studied 
to a great extent, the physical alterations of the bacterial outer membrane upon treatment with phenylene based 
cationic conjugated oligo- and polyelectrolytes are still underexplored. With a simplified backbone structure, 
phenylene based conjugated molecules can be ideal to explore the fundamental interactions with bacterial cells. 
In this work, we thus synthesized model cationic π-conjugated oligoelectrolytes (2QA-CCOE and 4QA-CCOE) 
and polyelectrolyte (CCPE) with phenylene based hydrophobic backbone and propoxy pendants terminated with 
cationic quaternary amine groups (Fig. 1). The ratios of phenyl groups to quaternary amine groups in CCPE, 
2QA-CCOE, and 4QA-CCOE were 1: 1, 3: 2, and, 3: 4, respectively. Prior reports showed evidence of changes 
in cell elasticity, hydrophilic/hydrophobic interactions, nanoscale morphology, and membrane permeability 
when β-lactam resistant E. coli were treated with ampicillin36. Even different strains of amp-resistant E. coli can 
exhibit different phenotypical traits36. Since the cell-drug interaction is highly dependent on the type of strains 
as well as the drug molecules used, it is critical to explore the interactions of conjugated small and large mole-
cules with both wild-type and amp-resistant bacterial strains side-by-side. In this work, we explored the antimi-
crobial activity of conjugated 2QA-CCOE, 4QA-CCOE, and CCPE molecules against wild-type (DH10B) and 
amp-resistant (SSBIO002) (explained in the supporting information) Gram-negative E. coli for a complex matrix 
of treatment conditions, including chemical structure and concentration of CCOE/CCPE in treatment systems 
as well as time and modes of treatments of bacterial cells. The killing efficiency (UV/Vis absorbance and flow 
cytometry); % growth inhibition (UV/Vis absorbance and colony-forming unit (CFU) assays); surface charge 
reversal (zeta potential analyzer); and, morphological changes (scanning electron microscopy (SEM), and fluores-
cence microscopy) of treated bacteria were explored. Such rigorous effort can greatly clarify our understanding of 
cell-conjugated molecule binding and growth inhibition mechanism from the viewpoint of fundamental changes 
on the bacterial membrane. This will also provide an informative framework for the rational design of antibiot-
ics, and fight against antibiotic resistance. Besides aiding in drug design, this effort to unravel bacteria-organic 
molecule interactions can assist in the development of coating for medical devices, wound healing materials, 
packaging materials for food safety, prevention of marine biofouling, wastewater treatment, microbial sensing, 
microbial fuel cells and more.
Results and Discussion
Synthesis and optical properties of ccoes and ccpe. For this specific study, we synthesized two 
phenylene based model oligoelectrolytes each with 3 phenyl groups along the backbone, and two (2QA-CCOE) 
or four (4QA-CCOE) propoxy pendants terminated with cationic quaternary amine groups (Fig. 1). The CCOEs 
were synthesized via Suzuki coupling and subsequent quaternization reaction (using ethyl bromide). We also 
synthesized cationic conjugated polyelectrolyte (CCPE) with phenylene based backbone following the procedure 
described in literature37 (Fig. 1). The step-by-step details of chemical synthesis and characterization to confirm 
the chemical structures of CCOEs and CCPE are discussed in supplementary information.
The absorbance maxima for 2QA-CCOE and 4QA-CCOE in water were at 301 nm and 266 nm, respectively 
(Fig. 2a). Since the larger number of cationic quaternary amine groups in 4QA-CCOE structure rendered higher 
water solubility, 4QA-CCOE showed an absorbance maxima blue-shifted from 2QA-CCOE. CCPE, on the 
other hand, showed structured absorption spectra with two peaks at 283 nm and 330 nm. A higher conjugation 
length of CCPE led to the emission maxima red-shifted from the CCOEs (Fig. 2b, λem, max = 375, 374, 413 nm, for 
2QA-CCOE, 4QA-CCOE and CCPE, respectively).
treatment of E. coli with ccpe/ccoe. The wild-type E. coli strain (DH10B) was transformed by appro-
priate plasmids to yield ampicillin-resistant (amp-resistant) E. coli strains (SSBIO002, see the experimental 
section, Supplementary Table S1 and other supporting information for details)38,39. Here, we treated E. coli sus-
pension (wild-type and amp-resistant) with conjugated molecules in multiple ways. We first followed two-step 
processes where the cells were incubated with conjugated molecules first (either in phosphate-buffered saline 
(PBS) or Luria Bertani (LB) medium) and then transferred to LB media to allow the bacteria grow further (treat 
(PBS or LB), then grow (LB)). In addition, we followed a one-step process where the E. coli cells were treated and 
grown at the same time in LB media (treat and grow (LB)).
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Figure 1. Synthetic routes to cationic conjugated oligoelectrolytes (2QA-CCOE, 4QA-CCOE) and 
polyelectrolyte (CCPE).
Figure 2. UV/Vis absorbance (a) and fluorescence (b) spectra of 2QA-CCOE, 4QA-CCOE, and CCPE in water.
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In the “treat (PBS), then grow (LB)” process, wild-type and amp-resistant E. coli were treated first by mixing 
bacterial suspension in 5 mM PBS buffer with 2QA-CCOE, 4QA-CCOE, and CCPE. We varied the concentration 
of 2QA-CCOE, 4QA-CCOE, and CCPE between 0–100 μM in PBS in order to study the effect of concentration 
of conjugated molecules on antimicrobial properties. The cells were treated with conjugated molecules for 0–6 h 
at 37 °C. It is to be noted that similar E. coli treatment in PBS buffer with conjugated molecules has been demon-
strated in several reports25,31,40. The utility of treating the bacteria in LB-free liquid (i.e. PBS here) is that the bacte-
ria do not grow further during the treatment and that allow us to elucidate the sole effect of conjugated molecules 
on a specific population of bacteria. For measuring the percent of dead cells during CCOE/CCPE treatment, we 
performed a live/dead assay using flow cytometry (Fig. 3). In this assay, SYTO9 and PI stains were used, where 
SYTO9 dye is able to stain both damaged and intact cells, while PI stains damaged cells only41,42. The percent (%) 
of dead cells in E. coli suspension after incubation with conjugated molecules were measured from this assay and 
varied between 9–14%. In addition, the absorbance of the bacterial suspension in PBS buffer varied insignificantly 
(absorbance at 600 nm ~0.45–0. 55, see Supplementary Fig. S1) as a function of time of incubation in CCOEs or 
CCPE during this step. The UV/Vis supported the findings of live/dead assay (Fig. 3) and the fact that CCPE and 
CCOEs did not kill wild-type or amp-resistant E. coli predominantly in PBS buffer (during the treatment period). 
While cell lysis or death20,43,44 did not happen during this CCOE/CCPE treatment step in PBS buffer, there were 
prominent interactions between conjugated molecules and the bacterial outer cell envelope during this step. The 
effect of these interactions was evident in the subsequent step in which these bacterial cells were allowed to grow 
in LB media and percent growth inhibition was calculated (Fig. 4).
Measurement of % growth inhibition. The CCOE/CCPE treated E. coli cells, when allowed to grow 
in LB media (“treat (PBS), then grow (LB)” process), the bacterial growth was efficiently inhibited (Fig. 4). The 
observed % growth Inhibition of E. coli (calculated using Eq. (1) as explained in Materials and Methods section) 
was consistently higher when E. coli was treated with CCPE in PBS before allowing it to grow in LB media (Fig. 4). 
Even when E. coli (both wild-type (Fig. 4a) and amp-resistant (Fig. 4c)) were treated with 50 μM CCPE for a 
few minutes (~3–5 min) in PBS, bacteria grew less than untreated bacteria and led to 40% growth inhibition. 
This indicated an instant action of CCPE on E. coli in PBS buffer. The % growth inhibition was 80% (Fig. 4b, 
wild-type) or above (Fig. 4d, amp-resistant) when CCPE concentration in treatment solution was increased from 
50 (Fig. 4a,c) to 100 μM (Fig. 4b,d). 2QA-CCOE and 4QA-CCOE were also able to inhibit the growth of E. coli, 
but needed longer treatment to generate the inhibitory effect similar to CCPE. We observed 95% growth inhi-
bition when E. coli cells were treated with 50 μM 4QA-CCOE or CCPE for 3 h. However, to achieve this level of 
growth inhibition with 2QA-CCOE, doubling the incubation time was required (6 h) (Fig. 4a,c). A higher con-
centration of conjugated molecules (100 μM, Fig. 4b,d) helped to reach ~99% growth inhibition faster (within 
~3–5 min, 1 h and 6 h with CCPE, 4QA-CCOE and 2QA-CCOE, respectively for amp-resistant E. coli (Fig. 4d)). 
In addition, both CCOEs and CCPE were able to inhibit the growth of antibiotic-resistant bacteria to a similar 
extent as wild-type strains. The fact that the bacteria were not dying during the treatment step with CCOE/
CCPE in PBS buffer, but not growing significantly when transferred to LB media evoked interest. The primary 
speculations were that it is either a straightforward effect of CCOE/CCPE attachment to bacteria which did not 
let the bacteria grow/divide further or an effect of PBS buffer during the treatment stage which negatively affected 
the metabolism of bacteria. Our control experiments showed that if the bacteria cells were kept in PBS buffer 
(without CCOE/CCPE) and later transferred to grow in LB media, the cells continued to grow in LB media. This 
suggests that possibly PBS buffer is not significantly affecting the metabolism. If something was decreasing the 
metabolism, it was likely the attachment and interaction of CCOE/CCPE with bacterial outer membrane. Zeta 
potential measurements (shown in a later section) will provide evidence of attachment of CCOEs/CCPE with 
bacterial cells.
Figure 3. Live/dead bacterial assay of wild-type E. coli treated with 4QA-CCOE and CCPE in PBS buffer. Each 
data point represents the mean and standard deviation of 2 replicates.
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Later, we measured the % growth inhibition following the other two treatment strategies mentioned ear-
lier (i.e. (“treat (LB), then grow (LB)” process), (Supplementary Fig. S2), and, “treat and grow (LB)” process 
(Supplementary Fig. S3, Supplementary Table S2). It appeared that none of these two processes were effective in 
exhibiting growth inhibition (Supplementary Fig. S2, Supplementary Table S2). Through calculation using maxi-
mum CCPE adsorption by bacteria (Supplementary Fig. S4), we found that the number of CCPE chains available 
in both of these treatment systems were much higher than that needed to effectively coat all the bacterial cells 
present. For example, by using 100 μM CCPE in the treatment system, we offered 1.06×1015 chains of CCPE/mL 
which is ~5 times higher than what was needed for achieving the most efficient coating of the cells. This suggested 
that not having enough CCPE (to coat bacteria) was not the root cause for the poor growth inhibition in these 
two treatment processes. One thing in common between “treat (LB), then grow (LB)” process, and, “treat and 
grow (LB)” process was: in both cases, CCOE/CCPE chains were in LB media. We thus hypothesized that the 
poor antimicrobial activity of CCOEs and CCPEs in LB media was due to high ionic strength of the LB media 
(171 mM) which led to charge screening of both bacteria and cationic conjugated molecules and minimized their 
electrostatic interactions. The hypothesis was supported by the zeta potential reported for E. coli cells in solution 
with various ionic strengths (discussed in detail in supporting information). Based on all these observations for 
different modes of treatment and culture, “treat (PBS), then grow (LB)” process (Fig. 4) appeared to be the most 
effective mode to attain bacterial growth inhibition.
The growth inhibition data for E. coli (“treat (PBS), then grow (LB)” process) was further supported by 
colony-forming unit (CFU) reduction assays done on agar plates (Fig. 5 and Supplementary Fig. S5 (wild-type), 
S6 (amp-resistant)). Briefly, 5 μL of CCOEs/CCPE-treated bacterial suspension (after 104 times dilution in 5 mM 
PBS) was spread over each agar plate and allowed to grow for 15 h (37 °C). % CFU reduction was calculated 
according to equation (2) as explained in Materials and Methods section. As the concentration of CCPE or 
4QA-CCOE in the treatment system increased, the E. coli growth on agar plates decreased gradually (i.e. % CFU 
reduction increased) (Fig. 5 and Supplementary Figs. S5 and S6). CCPE-treated E. coli showed the highest % CFU 
reduction, irrespective of CCPE concentration. Using a treatment system containing only 30 μM CCPE, ~90% 
CFU reduction was achieved which reached up to ~100% when CCPE concentration was ≥50 μM (Fig. 5). This 
suggested that CCPE can prevent the growth of wild-type E. coli similar to ampicillin if CCPE concentration is 
≥50 μM (Supplementary Fig. S7). On the other hand, using 30 μM 2QA-CCOE and 4QA-CCOE in a treatment 
system, ≤50% CFU reduction of wild-type E. coli (Fig. 5, left) was achieved. In the case of CCOEs, % CFU 
Figure 4. % growth inhibition of wild-type (a,b) and amp-resistant (c,d) E. coli in LB media for “treat (PBS), 
then grow (LB)” process. In this process, E. coli cells were treated first for 0–6 h in 50 μM (a,c) and 100 μM (b,d) 
of 2QA-CCOE, 4QA-CCOE, or CCPE in PBS. The cells were then transferred and allowed to grow in LB media 
for 3 h. Each data point represents the mean and standard deviation of 3 replicates.
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reduction approached to values close to that of CCPE at higher concentration of CCOEs. This CFU reduction 
data supported that CCPE based treatment is faster and more effective to inhibit the growth of E. coli than those 
based on CCOEs with lower concentration of the conjugated molecule. Also, 2QA-CCOE, unlike 4QA-CCOE 
and CCPE, led to anomalous growth and random values of CFU units rather than a gradual decrease (Fig. 5 and 
Supplementary Figs. S5 and S6) with the increase in 2QA-CCOE concentration. This could be attributed to the 
lower water solubility of 2QA-CCOE (~1 mg/mL) as compared to 4QA-CCOE, and CCPE (~20 mg/mL for both). 
The numbers of cationic quaternary amine groups for every 3 benzene rings along backbone were 2, 3 and 4 for 
2QA-CCOE, CCPE and 4QA-CCOE, respectively. The poor hydrophilicity made it difficult for 2QA-CCOE to 
consistently interact with the net negatively charged outer cell envelope of E. coli. On the other hand, a large num-
ber (~57) of RUs37, being wired in a chain, with a suitable charge density made CCPE more favorable to attach to 
the E. coli surface and inhibit the growth of E. coli more efficiently.
Zeta potential of ccoe/ccpe treated E. coli. During the treatment process, the zeta potential also sig-
nificantly changed as shown in Fig. 6. The untreated wild-type and amp-resistant E. coli  both were net negatively 
charged with zeta potential of ~−40 mV (Fig. 6) suggesting similar charged nature of  this specific E. coli strain 
after acquiring ampicillin resistance. Treatment with CCPE solution resulted in a large change in zeta poten-
tial (+15 mV (wild type, Fig. 6a) or +20 mV (amp-resistant, Fig. 6b)) of bacterial surface. Such a large surface 
charge reversal was expected based on high % CCPE adsorption on the bacteria surface (Supplementary Fig. S8). 
Interestingly, upon treatment with CCOEs, a much lower surface charge reversal of E. coli was observed 
(~−25 mV for both wild type and amp-resistant strains) at staining concentration ≥50 μM. Such a small change 
in zeta potential did not scale with the % mass adsorption, especially for 4QA-CCOE (about 65% mass adsorp-
tion of 4QA-CCOE (Supplementary Fig. S8d) was accompanied by a change in zeta potential from −37 mV to 
−27 mV only (Fig. 6)). We, therefore, believe that there are factors other than mass adsorption which controls 
the zeta potential (or surface charge) of E. coli treated with CCOE. Such a small increase in the zeta potential of 
bacteria treated with CCOEs was reported by others6,21,29,32,33 and attributed to the intercalation of CCOEs within 
the lipid bilayer of the outer membrane of E. coli. CCOEs with shorter chain length are more prone to membrane 
insertion32 and if the intercalation buries the CCOE chains and their cationic groups within lipid bilayer (rather 
than exposing the charges of CCOEs on the bacterial surface), the surface charge of bacteria may not change 
significantly despite CCOE adsorption.
The calculated backbone lengths of both 2QA-CCOE and 4QA-CCOE (~1.39 nm) were smaller than the thick-
ness of the lipopolysaccharide layer (~2.8 nm45, where the length of the core oligosaccharide6,45,46 part is ~2.1 nm) 
of the outer cell membrane of E. coli. Lipid bilayer intercalation is thus more probable with CCOEs. On the other 
hand, the long-chain CCPEs (~57 RUs) may experience steric hindrance to penetrate into the lipid bilayer and 
peptidoglycan layer of E. coli18,23. Moreover, large charge reversals, similar to our CCPE coated bacteria, have 
been observed for cell surfaces coated with many other long-chain polyelectrolytes47,48. In fact, a similar reversal 
of surface charge was reported for poly(fluorene) based CCPE coated E. coli30. Whitten et al.18,23 proposed that 
the biocidal activity of CCPEs may originate not just from their lipid membrane perturbation activity, but also 
from their interactions with the charged functional groups of lipid bilayer exposed to cell surfaces (contributed by 
zwitterionic phospholipid head groups; charged groups of outer and inner core oligosaccharides, and, Lipid A)5,49. 
Based on these pieces of evidence, we propose that long-chain CCPE (~50 nm based on length of RU~0.889 nm) 
are predominantly forming a coating on the outer cell envelope of E. coli. However, the likelihood of minor CCPE 
chain intercalation (alongside coating as a major mechanism) cannot be ruled out since complete charge reversal 
was not achieved.
Some of the already established models support our prediction of binding interactions and antimicrobial 
mechanisms18,50. Coating of bacterial outer cell envelope resembles the carpet model50,51 since the antimicrobial 
molecules, when following this model, orient themselves parallel to the membrane surface and cover the bacte-
rial surface, like a carpet (instead of inserting into the lipid membrane). On the other hand, CCOE intercalation 
Figure 5. % CFU reduction of wild-type (left) and amp-resistant (right) E. coli grown on agar plates after 
30 min treatment with 2QA-CCOE (light grey), 4QA-CCOE (green), and CCPE (blue) in PBS (2 step; “treat 
(PBS), then grow (LB)” process). The concentration of CCPE and CCOEs varied between 10 and100 μM. 
% CFU reduction values were calculated with respect to untreated cells (based on equation (2)). The data 
represents mean and standard deviation of 3 replicates for each treatment.
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can be explained by toroidal pore model18 based on which the membrane bound antimicrobial molecules insert 
into the lipid bilayer and force the outer leaflet to bend continuously to fuse with the inner leaflet of bacterial 
membrane18.
We also examined the effect of incubation time on the zeta potential of treated bacterial cells. A longer 
treatment time (6 h) did not change the zeta potential of treated bacteria much (Fig. 6(c,d)). Using 100 μM 
CCPE, ~99% growth inhibition of amp-resistant E. coli was achieved within 1 h (Fig. 4) which reached to 100% 
in the next 5 h. Additionally, the change in % mass adsorption (98% (1 h, Supplementary Fig. S8b); 98% (6 h, 
Supplementary Fig. S8d)) and zeta potential (+20 mV (1 h, Fig. 6b); +18 mV (6 h, Fig. 6d)) were minor. The 
results suggested that the adsorption of CCPE by bacteria was almost complete within 1 h of treatment and suf-
ficient to achieve high % growth inhibition. Interestingly, the zeta potential of 2QA-CCOE treated amp-resistant 
bacteria reached a plateau by 1 h (~−25 mV after 1 h (Fig. 6b); −28 mV after 6 h (Fig. 6d)), but the bacteria needed 
the full 6 h-treatment to achieve 98% growth inhibition (growth inhibition was 25% after 1 h treatment (Fig. 4d)). 
This suggested that growth inhibition of 2QA-CCOE was a time-dependent process. Rapid intercalation (within 
100 s, based on epifluorescence micrograph experiments) of CCOEs within the bacterial membrane was reported 
by Hinks et al.32 for oligo(phenylenevinylene) with 4 RUs and 4 quaternary amine groups. However, the times-
cales of their experimental (100 s) and simultaneous molecular dynamics simulation (200 ns) studies on mem-
brane perturbation of Gram-negative bacteria were very small and an understanding of membrane perturbation 
over large time scale is required. The reason is: to achieve 99% growth inhibition using 2QA-CCOE, cells had 
to be treated with 2QA-CCOE for a longer time (6 h), but within the first 1 h of this treatment time, adsorption 
of conjugated molecules by bacteria was complete. These results strongly suggested that after 1 h treatment, the 
already-attached CCOEs took part in dynamic membrane perturbation processes which continued for the next 
5 h of treatment. This led to time-dependent growth inhibition by CCOE treatment. Furthermore, there was no 
significant difference in the % mass adsorption of CCOE/CCPE on wild-type (Supplementary Fig. S8a,c) and 
amp-resistant (Supplementary Fig. S8b,d) E. coli and the resulting zeta potential (Fig. 6a,c vs 6b,d). These again 
supported that any specific type of conjugated molecule interacts with wild-type and amp-resistant E. coli (used 
in this study) in a similar manner.
Morphological changes upon treatment with ccoes/ccpe. Fluorescence microscopy images of 
green fluorescent protein (GFP)-incorporated amp-resistant E. coli suspension before and after treatment with 
Figure 6. Zeta potential of wild-type (a,c) and amp-resistant (b,d) E. coli suspension after treatment with 
CCOE/CCPE for 1 h (a,b) and 6 h (c,d) in 5 mM PBS buffer. Each data point represents the mean and standard 
deviation of 2 replicates.
8Scientific RepoRtS |         (2019) 9:20411  | https://doi.org/10.1038/s41598-019-56946-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
30 µM and 100 µM CCOEs/CCPE were captured (Supplementary Fig. S9). While CCOE-treatment did not change 
the size of E. coli aggregates (Supplementary Fig. S9a,b,c,e,f) and the cells were observed to spread out across the 
frame, bacteria started to aggregate significantly upon interaction with CCPE (Supplementary Fig. S9d,g). The 
size of aggregates (~15–20 μM) in CCPE (30 μM) treated E. coli suspension found from fluorescence microscopy 
image (Supplementary Fig. S9d) was similar to what obtained from SEM image (Fig. 7h). While interpreting 
the SEM data (Figure 7), we have to keep in mind that we are looking at 3D aggregates as a 2D image. Even 
though these are 2D images, the contrast can help us to understand the height wise growth of the aggregation. For 
untreated (Fig. 7a,e) and 30 μM of 2QA-CCOE-treated E. coli cells (Fig. 7b,f), the cells were lying flat like a single 
layer and spread out throughout the frame. When the cells were treated with 30 μM CCPE, the net negatively 
charged cells started to stick with each other in a three-dimensional manner due to electrostatic complexation 
assisted by cationic CCPE (Fig. 7d,h). In this case, the aggregates grew significantly along the third dimension, i.e. 
perpendicular to the image plane as evident from the image contrast (Fig. 7d,h). When the cells were treated with 
4QA-CCOE (30 μM, Fig. 7c,g), cells were aggregated, but the height wise growth was less than the cells treated 
with CCPE. Cationic CCPE chains, when coated the negatively charged E. coli cells, can attract other uncoated, 
negatively charged bacteria cells around and form larger aggregates (Fig. 7d,h). Intercalated CCOEs, on the other 
hand, are likely to conceal the positive charges of CCOEs and minimize the tendency to form bacterial aggregates 
(Fig. 7b,c,f,g).
Aggregates became larger and clearly grew in three dimensions when the concentration of CCPE in treatment 
solution increased from 0 μM to 100 μM (Fig. 8a–d for wild-type, 8e-h for amp-resistant E. coli) and seemed to be 
covered by CCPE molecules. No obvious cell wall rupture or cell lysis was predicted especially for CCOEs since 
the single cells in both treated (Fig. 7b,c,f,g) and untreated (Fig. 7a,e) E. coli suspensions looked smooth visually. 
Due to large aggregate formation, the individual cells could not be seen in the case of CCPE treated E. coli which 
made it difficult to comment about cell wall rupture/lysis based on SEM images. However, no GFP release from 
treated cells (Supplementary Fig. S9), low amount of dead cells based on live/dead assay (Fig. 3), and unchanged 
absorbance of treated bacteria (Supplementary Fig. S1) confirm no cell wall rupture/lysis upon treatment with 
CCPE. These results indicated that phenylene based CCOEs and CCPEs, unlike, phenylene ethynylene based 
ones18,23 (showing bacteriolytic activity), acted on the bacterial outer cell membrane more gently, but inhibited 
further growth. Having said that, the mild alterations at the single-cell level (non-bacteriolytic) could not be 
differentiated based on the SEM images (due to strong aggregation after treatment). But it is highly likely that 
mechanical changes are happening to some extent on bacterial outer cell envelope due to these treatments (cur-
rently under investigation). Finally, no significant difference in morphology between untreated wild-type (Fig. 7a) 
and amp-resistant (Fig. 7e) E. coli was observed and so was observed for treated ones (Fig. 7). This was consistent 
with the indifferent growth inhibition and zeta potential of these two strains.
conclusions. Through synthesizing phenylene based model cationic conjugated oligo- (2QA-CCOE, 
4QA-CCOE) and polyelectrolytes (CCPE), we studied the biophysical changes on the outer cell envelopes of 
wild-type and amp-resistant E. coli strains upon interactions with these conjugated molecules. These conju-
gated molecules inhibited the growth of both wild-type and amp-resistant E. coli to a similar extent. About 99% 
growth inhibition was achieved if amp-resistant E. coli was treated for ~3–5 min, 1 h, and 6 h in 100 μM of CCPE, 
4QA-CCOE, and 2QA-CCOE solutions, respectively. This indicated CCPE was a faster growth inhibitor of bac-
teria compared to oligomeric CCOEs. The better inhibitory activity of CCPE could be attributed to an optimum 
balance of side-chain hydrophilicity and backbone hydrophobicity, good water solubility as well as large chain 
Figure 7. SEM images of wild type (top panel) and amp-resistant (bottom panel) E. coli without treatment 
(a,e); treated with 30 µM 2QA-CCOE (b,f), 4QA-CCOE (c,g), and CCPE (d,h).
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length which made charge interaction of CCPE with net negatively charged bacteria more facile. The large charge 
reversal of bacteria upon treatment with CCPE suggested that bacterial cells were coated with CCPE chains. On 
the other hand, the low surface charge reversal suggested that CCOEs were intercalating within the lipid bilayer 
of the outer membrane of E. coli.
Materials and Methods
Bacteria culture. To make liquid growth media for E. coli, solid LB (Miller, AMRESCO) (25 g) was dissolved 
in DI water (1 L); while to make agar plates, solid LB (25 g) and agar powder (15 g) were dissolved in DI water 
(1 L). In both cases, the liquid LB media was autoclaved. Ampicillin (100 μg/mL) was then added to the media as 
needed. The liquid media was transferred to petri dishes to obtain solid agar plates. The agar plates were stored 
in the cold room (4 °C) till use. For each experiment, the E. coli strains stored in 15% glycerol were streaked on 
LB agar plates. The plates were incubated overnight at 37 °C. A single colony was then transferred into 4 mL of 
liquid LB media in 14 mL BD Falcon round-bottom culture tubes and incubated overnight at 37 °C in a shak-
er-incubator (250 rpm). Overnight grown cells were harvested by centrifugation (4700 rpm) for 15 min and the 
pellets were washed twice in 4 mL of 5 mM PBS. The cells were resuspended in 5 mM PBS and the optical density 
of resuspended cells measured at 600 nm (OD600) was then adjusted as needed using Genesys 10 S UV-Vis spec-
trophotometer (Thermo Fisher Scientific, Waltham, MA).
Live/dead assay. Live/dead assay of wild-type E. coli was done using LIVE/DEAD BacLight bacterial via-
bility and counting kit (Thermo Fisher Scientific, Waltham, MA) and samples prepared as described in the pro-
tocol52. Briefly, wild-type E. coli cells were grown for 8 h and OD600 was adjusted to 0.2 in 5 mM PBS. Cells were 
treated with CCOE/CCPE (10–50 μM) and incubated at 37 °C, 250 rpm for 1 h. Treated cells were harvested; 
centrifuged at 10000 × g for 3 minutes; pellets were washed twice with 0.85 wt % NaCl in water and resuspended 
in 1 mL of 0.85 wt% NaCl solution. Samples were then diluted in two steps: In the first step, the cells were diluted 
with appropriate volume of 0.85 wt% NaCl solution to achieve OD600 of bacterial suspension as 0.125; this cell sus-
pension was then further diluted to obtain 1 million cells/mL by adding 10 µL of cell suspension (OD600 = 0.125) 
to 987 µL of 0.85% NaCl solution. Finally, 3 µL of mixed SYTO9 and PI (1:1 v/v) was added to the cell suspension 
and used for flow cytometry. Each treatment had 2 replicates. BD FACSAria II (Franklin Lakes, NJ) at Nebraska 
Center for Biotechnology at University of Nebraska-Lincoln was then used for flow cytometry studies. BD 
FACSDiva software was used to analyze the flow cytometry data and obtain % of damaged cells.
Absorbance measurement upon ccoe/ccpe treatment. CCOE/CCPE and cell suspension were 
added together in 5 mM PBS ([CCOE/CCPE]after adding to PBS = 0–100 μM (based on RUs); absorbance of E. coli 
at 600 nm ~0.5 (initially); final volume = 250 μL). The suspension was incubated for 0–6 h (37 °C, 250 rpm). The 
change in absorbance at 600 nm was measured using i3xplate reader (Molecular Devices, San Jose, CA). The study 
was performed for both wild-type (DH10B) and amp-resistant E. coli (SSBIO002) (as shown in Supplementary 
Fig. S1)). This procedure was followed to replicate the data three times.
Measurement of percent (%) growth inhibition. The growth inhibition was studied in three ways: 
“treat and grow (LB)” (1-step-process); “treat (PBS), then grow (LB)” (2-step-process); and “treat (LB), then grow 
(LB)” (2-step-process). For the 1-step process, the CCOE/CCPE and cell suspension were added together in LB 
media ([CCOE/CCPE]after adding to LB = 0–100 μM (based on RUs); OD600, initial = 0.2; final volume = 250 μL) and the 
cells were allowed to grow here for 0–6 h (37 °C, 250 rpm). For the 2-step processes, the procedure was similar to 
Figure 8. SEM images of wild type E. coli (top panel) and amp-resistant E. coli (bottom panel), without 
treatment (a,e); treated with 10 µM (b,f), 30 µM (c,g), and 100 µM CCPE (d,h).
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what described in the literature22. At first, the E. coli strains (OD600, initial = 0.2) were treated with CCOE/CCPE for 
0–6 h (37 °C, 250 rpm) in PBS (for “treat (PBS), then grow (LB)” process) or LB (for “treat (LB), then grow (LB)” 
process). After that, 50 μL of this treated cell suspension was transferred to 200 μL of LB media in black 96-well 
plates and allowed to grow for 3 h (37 °C, 250 rpm). The percent (%) growth inhibition of E. coli in LB media was 
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Each absorbance value was background subtracted where the background was the absorbance of the sample 
at time = 0 (i.e. just after adding to LB media).
colony-forming unit (cfU) reduction assay. The protocol described in the literature was used for CFU 
reduction studies25. Briefly, the bacterial strains grown in liquid LB media were used and OD600 was adjusted to 
0.2 by dilution with 5 mM PBS buffer. 180 μL of this E. coli suspension was transferred to black 96-well plates to 
which appropriate volume of a type of conjugated molecule (i.e., 2QA-CCOE, 4QA-CCOE, or CCPE) was also 
added. The final concentration of CCOEs or CCPE in this pretreatment step varied between 0 and 100 μM (based 
on RUs). The treated bacterial cells were diluted 104 times using 5 mM PBS. 5 μL of this diluted bacterial suspen-
sion was then spread on top of the agar plates (3 replicates for each treatment) and allowed to grow in dark for 
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Plain LB and LB-supplemented with ampicillin (100 μg/mL) were used to grow the wild-type and 
amp-resistant strains, respectively. The CFUs for untreated amp-resistant E. coli grown on an agar plate with 
and without ampicillin were almost similar (Supplementary Fig. S10). This confirmed the effectiveness of colony 
selection process and growth of amp-resistant E. coli only (i.e. no growth of wild-type E. coli). Also, the wild-type 
and amp-resistant E. coli were grown on agar plates made of LB supplemented with ampicillin (Supplementary 
Fig. S11). While the amp-resistant E. coli grew on agar plates, there was no colony formation for wild-type E. coli. 
This confirmed that just amp-resistant E. coli was able to grow.
Zeta potential measurement. Both wild-type and amp-resistant E. coli samples were treated with CCOEs 
or CCPE (as mentioned in prior sections) after which the cells were harvested by centrifugation (4700 rpm, 
15 min). The pellets were washed twice with DI water (2 ml per wash) and then resuspended in 2 mL DI water for 
subsequent zeta potential measurement using Zeta PALS Zeta Potential Analyzer (Brookhaven Holtsville, NY).
Scanning electron microscope (SeM) imaging. For the investigation of the morphology of untreated 
and CCPE/CCOE treated E. coli, scanning electron microscope (SEM; Nova NanoSEM450, FEI, Hillsboro, OR) 
was performed at Nebraska Center for Materials and Nanoscience. 900 μL of bacterial suspension (OD600 = 0.2) 
and different concentrations of CCPE or CCOEs (0–100 μM) were mixed and incubated for 1 h in culture tubes 
(37 °C, 250 rpm). The treated cells were harvested by centrifugation (4700 rpm, 15 min) and pellets were washed 
twice (with 1 mL of DI water per wash) and resuspended in 1 mL DI water. 3 μL of this suspension was added 
on top of a silicon wafer (0.5 cm × 0.5 cm) and allowed to dry at room temperature for 1 h. Dried samples were 
fixed with 0.5 vol% glutaraldehyde in 5 mM PBS buffer and kept at room temperature for another hour. This was 
followed by a second fixing using 1 vol% glutaraldehyde in 5 mM PBS and samples were kept at room temperature 
for 4 h. Fixed cells were washed thrice with DI water and dehydrated sequentially using 20, 30, 50, 70, 90 and 
100 vol% of ethanol in water. Finally, the specimens were coated with gold prior to SEM measurement.
Data availability
All data generated and analyzed in this study are included in main text or Additional Information.
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